Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.49
Bid: 6.00
Ask: 6.98
Change: -0.10 (-1.52%)
Spread: 0.98 (16.333%)
Open: 6.59
High: 0.00
Low: 0.00
Prev. Close: 6.59
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: FTSE 100 Closes Slightly Higher Amid Iraqi Tensions

Thu, 12th Jun 2014 16:37

LONDON (Alliance News) - The FTSE 100 closed fractionally higher Thursday, having spent the day trading within a tight range, with oil and gas exploration and production company BG Group leading the gains as the price of oil climbed amid escalating violence in Iraq.

BG Group ended the day as the biggest riser in the blue-chip index, closing up 2.5%, benefiting from the increasing price of oil while not itself having any operations in Iraq exposed to the unrest.

Brent and West Texas Intermediate oil prices jumped sharply amid escalating violence in Iraq, where militants are fighting towards Baghdad. At the UK equity market close, Brent was trading up 1.9% at USD112.14 per barrel, while WTI was up 1.5% at USD105.96 per barrel.

A session of the Iraqi parliament called to vote on declaring a nationwide state of emergency has been adjourned due to lack of quorum, even as radical jihadists pressed ahead towards the capital of Baghdad. No date has been set for the next parliamentary meeting, independent Alsumaria TV said, a fiasco set to deepen Iraq's political and security woes.

In the latest developments, the Islamic State in Iraq and the Levant claims on Twitter that it has captured 4,500 Iraqi soldiers in Salah al-Din province, north of Baghdad. Videos posted on YouTube by apparent ISIL supporters showed a column of hundreds of unarmed men in civilian clothes being marched along a highway.

"The unrest in the country has raised fears over supply of crude from the region," said Fawad Razaqzada, a technical analyst at Forex.com. "The situation in Libya also remains out of control where many oilfields and oil export terminals remain under the occupancy of armed insurgents. Should the situation in these countries deteriorate, or worse spread to the neighbours, crude price could potentially climb further higher," he added.

The violence has not been beneficial for all oil and gas companies, however, with Afren and Gulf Keystone, both of which operate in Iraq, closing down 1.7% and 1.8%, respectively, after falling sharply Wednesday as well.

Overall, UK stocks closed mixed Thursday. The FTSE 100 closed up 0.1% at 6,843.11, the FTSE 250 closed up 0.2% at 16,125.95, and the AIM All-Share index closed down 0.5% at 795.18.

In Europe, the CAC 40 in Paris closed down 0.02%, and the DAX 30 in Frankfurt closed down 0.1%.

Meanwhile, on Wall Street, at the UK equity market close, the DJIA, S&P 500, and NASDAQ Composite were all down between 0.2% and 0.3%.

Prior to the NY open, US stock futures had been pointing to a marginally higher open, but turned negative shortly after the latest batch of US data came in below expectations.

US retail sales expanded by 0.3% in the month of May, following an upwardly revised 0.5% increase in April. Economists had been expecting sales to climb by about 0.6% in May compared with the 0.1% uptick originally reported for the previous month. Excluding car sales, retail sales were up by just 0.1% over the month, compared with a 0.4% increase in April. Ex-auto sales were originally reported as unchanged in the previous month.

Initial jobless claims, released at the same time, also disappointed, rising to 317,000 in the week ended June 6, from 313,000 in the previous week, more than the 310,000 that economists had forecast.

In the forex market, the dollar softened across the board Thursday. At the close of the UK equity market, the dollar was trading at JPY101.840, while the pound was at USD1.6848 and the euro at USD1.3551.

Mining companies Anglo American, Rio Tinto, Glencore and BHP Billiton were all amongst the heaviest blue-chip fallers Thursday, amid concerns over commodity prices and consequential share price target reductions by analysts at Morgan Stanley.

Morgan Stanley’s metals and minerals commodity economist Joel Crane lowered his iron-ore price assumptions for 2014 to 2019. For the second half of the current year, the analyst cut Morgan Stanley's assumed iron ore price by more than 17% to USD95 per metric ton. For the 2015 full-year, the assumed price has been slashed by almost 24% to USD87. The long-term price for 2020 and beyond remains unchanged at USD99 per metric ton in real terms, meaning adjusted for inflation.

"The cuts reflect a faster and more pronounced mean reversion in the iron ore price in reaction to accelerating supply growth than we anticipated," Morgan Stanley said in a morning note to investors.

Morgan Stanley downgraded Anglo American to Underweight from Equal Weight, lowering its price target to 1,360.00 pence from 1,530.00p, saying that the market is too optimistic on the miner's cost reduction plans, and that its exposure to iron ore exceeds that of other miners. It also lowered BHP Billiton's price target to 2,200.00 pence from 2,140.00p, and Rio Tinto's 3,430.00 pence from 3,820.00p.

Anglo American closed down 3.2%, Rio Tinto down 3.1%, BHP Billiton down 1.8%, and Glencore down 1.3%. The FTSE 350 mining sector index closed down 1.9% at a near three-month low.

The downgrade was enough to see Anglo American end the day as the biggest faller in the FTSE 100, even though FTSE 250-listed Lonmin said it had reached a tentative deal over wages and working conditions with the leadership of the union that has crippled the South African platinum mining industry for several months.

The company said the two sides have reached "informal undertakings" in principle on a potential deal. Peers Anglo American Platinum, part of Anglo American, and Impala Platinum Holding have received the same in principle undertakings, it added.

"The companies expect to receive feedback from the Association of Mineworkers and Construction Union on Friday, 13 June. Thereafter, and should an agreement be reached, the companies will be assisting employees to ensure a safe return to a normal working environment," Lonmin said.

Lonmin, which had moved lower in early trade, managed to end the day up 8.9% as the mid-cap index's biggest riser, following the announcement.

Elsewhere, ITV ended the day as one of the biggest risers in the FTSE 100, closing up 1.6%. Shares in the television company rose after trade magazine Media Week reported that US advertising and marketing agency Omnicom Group Inc has decided to halt all media spend with Channel 5 until the end of the year, redirecting advertising activity to ITV instead.

The move is reported to have been made without any discussions with Channel 5, with many in the industry suggesting that ITV is receiving the extra spend due to its relationship with Omnicom's media trading arm Opera, the magazine reported.

Opera is said to have spent more than GBP50 million on Channel 5 last year.

"ITV looks to have gained a major boost, with one of the main media buying groups reportedly stopping spending with Channel 5 in the second half of the year and shifting this money across to ITV," said Liberum Capital analyst Ian Whittaker.

Earlier in the day, Whittaker sent a research note to investors saying that the fact ITV's shares have spent June trading in tight ranges should be used as a buying opportunity. "While we like it for long-term, fundamental reasons, shorter-term advertising trends also provide a catalyst," Whittaker said. "In this context, the suggestions that advertising momentum is improving around the World Cup should help," he said.

Imperial Tobacco Group, closing up 0.9%, was another big winner. The company's shares moved higher after Reuters reported that the group is considering a deal to buy assets that are likely to be sold by US tobacco companies Reynolds American Inc and Lorillard Inc if they go ahead with a proposed merger.

AstraZeneca ended the day up 0.5%. The pharmaceuticals giant said it had signed a global licence agreement with AIM-listed biotechnology company Synairgen for its SNG001 compound for the treatment of infections that exacerbate asthma. Under the terms of the deal, AstraZeneca will pay Synairgen an up-front free of USD7.25 million, with potential milestone payments of up to USD225 million possible.

Separately, AstraZeneca and Amgen said late Wednesday that phase II study results of psoriatic arthritis drug brodalumab showed that the treatment showed significant improvement in clinical symptoms.

The results, which were published in the New England Journal of Medicine, and will be presented at the 2014 European League Against Rheumatism congress in June, also showed that many patients continued to improve and saw sustained improvements. The companies said that the encouraging data from the study was why they had opted to continue developing brodalumab as a potential treatment for psoriatic arthritis.

In the FTSE 250, Halma, closing up 4%, was one of the index's riser. The technology company upped its total dividend for the year to end-March and expressed confidence for further growth in the year ahead, as it saw pretax profit rise, boosted by strong revenue growth in the US, UK and mainland Europe.

It posted a pretax profit of GBP138.7 million, up 15% from GBP120.1 million, as it saw revenue rise 9.3% to GBP676.5 million from GBP619.2 million. It proposed a total dividend of 11.17 pence, up 7.1% from 10.43p in the previous year.

Also in the mid-cap index, Premier Farnell closed up 3.3% after it said it will restructure its business for an estimated cost of GBP8 million to secure yearly cost savings of GBP6 million to GBP8 million. It said the cost benefits will be minimal in the current financial year, with the full benefit anticipated for the 2016 financial year. The company also said it was continuing to trade in line with its forecast at the time of its interim management statement in May.

Still to come Thursday, Bank of England Governor Mark Carney and Chancellor of the Exchequer George Osborne are due to give speeches at a Mansion House dinner.

“Given recent firmer economic data, the tone of these will probably be more upbeat than in recent years,” said Rhys Herbert, senior economist at Lloyds Bank. While it is unlikely that either will use the occasion to announce new initiatives, markets will be looking for any hints of possible action from the Financial Policy Committee, Herbert added.

In the data calendar on Friday, the Bank of Japan releases its latest interest rate decision and monetary policy statement at 0400 BST. Japanese industrial production and capacity utilisation data for April are released at 0530 BST, shortly before Chinese industrial production, retail sales, and urban investment data for May at 0630 BST.

German consumer price inflation figures are released at 0700 BST, with the Spanish and Italian equivalents due at 0800 BST and 0900 BST, respectively. Employment change and trade balance data for the eurozone is scheduled for 1000 BST.

In the US, producer price inflation is published at 1330 BST, with the preliminary Reuters/Michigan consumer sentiment index released at 1455 BST.

In the corporate calendar, AIM All-Share index-listed Bonmarche Holdings is due to release full-year results Friday.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
5 Sep 2022 10:42

Synairgen to collaborate with University of Southampton on observational study

(Sharecast News) - Drug discovery outfit Synairgen will collaborate with the University of Southampton on an observational study aimed at exploring and better understanding acute respiratory viral infections and recovery.

Read more
23 Jun 2022 16:02

UK shareholder meetings calendar - next 7 days

Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
Tuesday 28 June 
4D Pharma PLCAGM
Acceler8 Ventures PLCAGM
Airtel Africa PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Attraqt Group PLCAGM
Bay Capital PLCAGM
Capital & Counties Properties PLCAGM
CMO Group PLCAGM
Corre Energy BVAGM
Creo Medical Group PLCAGM
Futura Medical PLCAGM
Gama Aviation PLCAGM
ICG Enterprise Trust PLCAGM
ImmuPharma PLCAGM
IQE PLCAGM
Katoro Gold PLCAGM
Rockhopper Exploration PLCAGM
Sound Energy PLCAGM
TP Group PLCAGM
UK Oil & Gas PLCAGM
Volvere PLCAGM
Zegona Communications PLCAGM
Wednesday 29 June 
Africa Opportunity Fund LtdAGM
Argo Blockchain PLCAGM
Atome Energy PLCAGM
Brave Bison Group PLCAGM
Concurrent Technologies PLCAGM
Eden Research PLCAGM
Facilities by ADF PLCAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Hurricane Energy PLCAGM
i(x) Net Zero PLCAGM
Lords Group Trading PLCAGM
MaxCyte IncAGM
Meggitt PLCAGM
Mobile Tornado Group PLCAGM
NB Distressed Debt Investment Fund LtdAGM
NetScientific PLCAGM
Provident Financial PLCAGM
RA International Group PLCAGM
Reabold Resources PLCAGM
Symphony Environmental Technologies PLCAGM
Team17 Group PLCAGM
ThinkSmart LtdGM re approval for capital return
Trinity Exploration & Production PLCAGM
URA Holdings PLCAGM
XP Factory PLCAGM
Zaim Credit Systems PLCAGM
Thursday 30 June 
3i Group PLCAGM
Ashtead Technology Holdings PLCAGM
Borders & Southern Petroleum PLCAGM
Caspian Sunrise PLCAGM
Cobra Resources PLCAGM
Crimson Tide PLCAGM
ECSC Group PLCAGM
Evraz PLCAGM
Gresham House Energy Storage Fund PLCAGM
GRIT Investment Trust PLCAGM
Gulf Marine Services PLCAGM
Hamak Gold LtdAGM
Hemogenyx Pharmaceuticals PLCAGM
Immotion Group PLCAGM
Inspiration Healthcare Group PLCAGM
Inspired PLCAGM
Jadestone Energy PLCAGM
Kanabo Group PLCAGM
Kropz PLCAGM
Likewise Group PLCAGM
Live Co Group PLCAGM
Location Sciences Group PLCAGM
LoopUp Group PLCAGM
M&C Saatchi PLCAGM
Microsaic Systems PLCAGM
Nostra Terra Oil & Gas CoAGM
Pathfinder Minerals PLCAGM
Playtech PLCAGM
Primorus Investments PLCAGM
Rockfire Resources PLCAGM
Roquefort Therapeutics PLCAGM
Sanne Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serica Energy PLCAGM
Supply@ME Capital PLCAGM
Surface Transforms PLCAGM
Synairgen PLCAGM
Tower Resources PLCAGM
Trainline PLCAGM
ValiRx PLCAGM
Victoria Oil & Gas PLCAGM
Watchstone Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
25 May 2022 12:00

IN BRIEF: Synairgen shares fall as loss widens on higher costs

Synairgen PLC - Southampton, England-based drug discovery and biotechnology company - Records a pretax loss of GBP57.9 million in 2021, widened from GBP17.7 million in 2020, as research and development costs jump to GBP52.9 million from GBP15.5 million. Further, administrative expenses more than double to GBP5.0 million from GBP2.2 million. Explains this with its phase 3 Sprinter trial that started patient recruitment in January 2021. The trial is for SNG001, an inhaled drug for the treatment of Covid-19. Says the remainder of the research and development expenditure was used for upscaling SNG001 manufacturing development activities and procuring long lead time components.

Read more
16 May 2022 15:23

Synairgen posts positive clinical trial data for SNG001

(Sharecast News) - Shares of Synairgen caught a bid following the release of clinical trial results which appeared to show that its SNG001 formulation against Covid-19 might lower the risk of severe disease or death in the most at risk patients.

Read more
16 May 2022 12:18

LONDON MARKET MIDDAY: FTSE 100 edges into green but grey clouds remain

(Alliance News) - The FTSE 100 index put a toe into positive territory by midday on Monday, reclaiming all the ground lost earlier in the morning, but investors continue to fret about poor economic data from China.

Read more
16 May 2022 12:18

IN BRIEF: Synairgen shares soar on positive analysis of SNG001

Synairgen PLC - Southampton, England-based drug discovery and biotechnology company - Notes that it announced in February that its phase 3 Sprinter trial did not meet its primary endpoints of discharge from hospital and recovery. Says that the trial still showed an encouraging signal in the reduction in the relative risk of progression to severe disease or death within 35 days. Says that it performed a post hoc analysis on groups of patients recognised to be at greater risk of developing severe disease in hospital, to assess the strength of this signal. Says that the analyses showed stronger treatment effects with SNG001 in high-risk patient sub-groups, with the strongest effect observed in those who had clinical signs of compromised respiratory function. Says SNG001 significantly reduced the risk of progression to severe disease and death compared to a placebo by 70% in the per-protocol population.

Read more
17 Mar 2022 12:32

Synairgen falls as patient recruitment halted on Covid-19 trial

(Sharecast News) - Inhaled antiviral treatment developer Synairgen said on Thursday that the US National Institute of Allergy and Infectious Diseases (NIAID) has halted all patient recruitment in its phase 2 and 3 Covid-19 trial, which included the assessment of its 'SNG001' treatment.

Read more
17 Mar 2022 11:48

IN BRIEF: Synairgen falls as patient recruitment in US trial halted

Synairgen PLC - Southampton, England-based drug discovery and biotechnology company - Says the US National Institute of Allergy & Infectious Diseases has halted all patient recruitment in its phase 2/3 Covid-19 trial. The trial included the assessment of its inhaled SNG001 drug.

Read more
17 Mar 2022 11:21

AIM WINNERS & LOSERS: Synairgen sinks 18% after US Covid study halted

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
3 Mar 2022 20:34

TRADING UPDATES: Next Fifteen raises GBP50 million; N Brown sales up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
3 Mar 2022 12:20

Synairgen asked to pause activities on Covid-19 treatment trial

(Sharecast News) - Synairgen announced on Thursday that it was pausing clinical trial activities on its 'SNG001' compound in the treatment of Covid-19, at the behest of American authorities.

Read more
3 Mar 2022 11:29

AIM WINNERS & LOSERS: dotDigital plunges after profit warning

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
21 Feb 2022 12:25

Synairgen falls as trial for Covid treatment fails to meet endpoints

(Alliance News) - Synairgen PLC shares hit a 12-month low on Monday after the biotechnology company said that the late-stage trial of its Covid-19 treatment SNG001 did not meet primary or key secondary efficacy endpoints.

Read more
21 Feb 2022 11:33

AIM WINNERS & LOSERS: Morses Club sinks on profit warning, CEO exit

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Feb 2022 09:27

Synairgen shares plunge as Covid-19 treatment trial fails

(Sharecast News) - Synairgen announced on Monday that the international phase 3 trial of its SNG001 antiviral inhalation in patients hospitalised with Covid-19 did not meet its primary or key secondary endpoints.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.